IE
PRPH

Israel Englander’s ProPhase Labs PRPH Stock Holding History

Israel Englander’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,689
Closed -$259K – 6750
2022
Q4 		$259K Sell
2,689
-12,831
-83% -$1.39M ﹤0.01% 5185
2022
Q3 		$1.75M Buy
15,520
+12,964
+507% +$1.51M ﹤0.01% 3866
2022
Q2 		$324K Buy
+2,556
New +$225K ﹤0.01% 5300
2021
Q3 		– Sell
-4,658
Closed -$289K – 7141
2021
Q2 		$289K Buy
4,658
+2,901
+165% +$163K ﹤0.01% 5756
2021
Q1 		$130K Buy
+1,757
New +$169K ﹤0.01% 5632
2017
Q3 		– Sell
-2,566
Closed -$54K – 3789
2017
Q2 		$54K Buy
+2,566
New +$51.5K ﹤0.01% 3356

Other funds holding PRPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AWE
Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Israel Englander's PRPH Position: Q1 2023 in Review

Israel Englander sold out of ProPhase Labs (PRPH) in Q1 2023, closing a stake of 2,689 shares — an estimated $259K sold.

Israel Englander first reported a position in PRPH in Q2 2017 and held it in 6 quarters. The position peaked at $1.75M in Q3 2022. 39 funds tracked by Wall St. Rank hold PRPH as of Q1 2023.

  • Israel Englander reported no remaining ProPhase Labs position as of Q1 2023 after selling out during the quarter.
  • Israel Englander sold 2,689 ProPhase Labs shares in Q1 2023, an estimated $259K.
  • Israel Englander first reported a position in ProPhase Labs in Q2 2017 and held it in 6 quarters.
  • Israel Englander's ProPhase Labs position peaked at $1.75M in Q3 2022.
  • 39 funds tracked by Wall St. Rank held ProPhase Labs as of Q1 2023.

Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.